SARAH EVANS: Open Payments
NPI 1922358555 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,874 in 81 payments from 24 companies in 2025. Trend: 2023 $1,018 · 2024 $1,732 · 2025 $1,874
Food & beverage: $1,813Education: $61
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 8 | $197 |
| AstraZeneca Pharmaceuticals LP | 10 | $190 |
| KYOWA KIRIN, INC. | 2 | $159 |
| Travere Therapeutics, Inc. | 7 | $157 |
| Ardelyx, Inc. | 3 | $152 |
| Novartis Pharmaceuticals Corporation | 7 | $151 |
| Amgen Inc. | 8 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $107 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| Apellis Pharmaceuticals, Inc. | 5 | $97 |
Products named: Vafseo, CRYSVITA, XPHOZAH 30 MG, REPATHA, FARXIGA, Kerendia, JYNARQUE, Empaveli.
Industry payments across PA — which companies pay providers there.
